Home > News > Kylin to collaborate on RNAi research
October 2nd, 2007
Kylin to collaborate on RNAi research
Abstract:
West Lafayette-based Kylin Therapeutics has agreed to collaborate with Fort Dodge Animal Health, a division of Wyeth, to develop new therapeutics to treat cancer.
Under the three-year agreement, Kylin will receive research funding and royalties to use its patented nanoparticle technology, called pRNA, to further study RNA interference and to develop RNA-based therapeutics.
Source:
indystar.com
Related News Press |
Nanomedicine
New micromaterial releases nanoparticles that selectively destroy cancer cells April 5th, 2024
Good as gold - improving infectious disease testing with gold nanoparticles April 5th, 2024
Researchers develop artificial building blocks of life March 8th, 2024
Announcements
NRL charters Navy’s quantum inertial navigation path to reduce drift April 5th, 2024
Discovery points path to flash-like memory for storing qubits: Rice find could hasten development of nonvolatile quantum memory April 5th, 2024
Alliances/Trade associations/Partnerships/Distributorships
Chicago Quantum Exchange welcomes six new partners highlighting quantum technology solutions, from Chicago and beyond September 23rd, 2022
University of Illinois Chicago joins Brookhaven Lab's Quantum Center June 10th, 2022
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||